ADR Biomedical Holdings Inc. (TYO:3750)

ADR Biomedical Holdings Revenue

In the fiscal year ending March 31, 2026, ADR Biomedical Holdings had annual revenue of 50.00M JPY, down -59.02%. ADR Biomedical Holdings had revenue of 17.00M in the quarter ending March 31, 2026, with 142.86% growth.

• Revenue: 50.00M
• Revenue Growth: -59.02%
• P/S Ratio: 141.60
• Revenue / Employee: 3.85M
• Employees: 13
• Market Cap: 7.08B

Revenue Chart

Chart

Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Mar 31, 2026	50.00M	-72.00M	-59.02%
Mar 31, 2025	122.00M	-1.44B	-92.18%
Mar 31, 2024	1.56B	-584.00M	-27.24%
Mar 31, 2023	2.14B	809.00M	60.60%
Mar 31, 2022	1.34B	-53.00M	-3.82%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Aug 1, 2026

Data Sources Report a data error